Johnson & Johnson's total sales 2005-2022

In 2022, Johnson & Johnson's generated approximately 95 billion U.S. dollars in sales. This statistic shows the global total sales of Johnson & Johnson from 2005 to 2022. Johnson & Johnson is a multinational company, specialized in pharmaceuticals, medical devices, and consumer goods. The company is headquartered in New Brunswick, New Jersey.

Johnson & Johnson’s global position

Johnson & Johnson has been ranked among the top pharmaceutical companies globally in recent years and in multiple categories. As of 2022, it was ranked as the top leading pharmaceutical company worldwide in terms of total revenue generated. Furthermore, Johnson and Johnson was also the fourth leading pharmaceutical company globally by prescription sales revenue in 2021, as well as being the fourth leading company worldwide in terms of its research and development spending.

Johnson & Johnson’s research and development

As of 2022, Johnson and Johnson was not among the big pharmaceutical companies with the highest R&D intensity. Johnson and Johnson’s research and development expenditure has been steadily and gradually increasing in the past five years. In 2022, the company spent around 14.6 billion U.S. dollars on research and development, accounting for around 15 percent of total sales revenue that year.